Successful treatment of meticillin-resistant Staphylococcus aureus bacteraemia in a neonate using daptomycin

References

1. Abdel-Rahman S. M., Benziger D. P., Jacobs R. F., Jafri H. S., Hong E. F., Kearns G. L. 2008; Single-dose pharmacokinetics of daptomycin in children with suspected or proved gram-positive infections. Pediatr Infect Dis J 27:330–334 [CrossRef]
   [Google Scholar]
2. Carey A. J., Long S. S. 2010; Staphylococcus aureus : a continuously evolving and formidable pathogen in the neonatal intensive care unit. Clin Perinatol 37:535–546 [CrossRef]
   [Google Scholar]
3. Cohen-Wolkowiez M., Smith P. B., Benjamin D. K. Jr, Fowler V. G. Jr, Wade K. C. 2008; Daptomycin use in infants: report of two cases with peak and trough drug concentrations. J Perinatol 28:233–234 [CrossRef]
   [Google Scholar]
4. Dvorchik B. H., Brazier D., DeBruin M. F., Arbeit R. D. 2003; Daptomycin pharmacokinetics and safety following administration of escalating doses once daily to healthy subjects. Antimicrob Agents Chemother 47:1318–1323 [CrossRef]
   [Google Scholar]
5. Hawkey P. M. 2008; Pre-clinical experience with daptomycin. J Antimicrob Chemother 62 (Suppl. 3):iii7–iii14
   [Google Scholar]
6. Johnson A. P., Sharland M., Goodall C. M., Blackburn R., Kearns A. M., Gilbert R., Lamagni T. L., Charlett A., Ganner M. other authors 2010; Enhanced surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in children in the UK and Ireland. Arch Dis Child 95:781–785 [CrossRef]
   [Google Scholar]
7. Kanafani Z. A., Corey G. R. 2007; Daptomycin: a rapidly bactericidal lipopeptide for the treatment of Gram-positive infections. Expert Rev Anti Infect Ther 5:177–184 [CrossRef]
   [Google Scholar]
8. Lodise T. P., Graves J., Evans A., Graffunder E., Helmecke M., Lomaestro B. M., Stellrecht K. 2008; Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin. Antimicrob Agents Chemother 52:3315–3320 [CrossRef]
   [Google Scholar]
9. Moise P. A., Sakoulas G., Forrest A., Schentag J. J. 2007; Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteraemia. Antimicrob Agents Chemother 51:2582–2586 [CrossRef]
   [Google Scholar]
10. Tobin C. M., Darville J. M., Lovering A. M., Macgowan A. P. 2008; An HPLC assay for daptomycin in serum. J Antimicrob Chemother 62:1462–1463 [CrossRef]
    [Google Scholar]
11. Yoon Y. K., Kim J. Y., Park D. W., Sohn J. W., Kim M. J. 2010; Predictors of persistent methicillin-resistant Staphylococcus aureus bacteraemia in patients treated with vancomycin. J Antimicrob Chemother 65:1015–1018 [CrossRef]
    [Google Scholar]